02/05/2020 12:00 AM EST
Source: American Academy of Pediatrics (AAP). Published: 2/5/2020. This chapter from Red Book 2018 provides information about coronaviruses, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). It discusses clinical manifestations, etiology, epidemiology, diagnostic tests, treatment, isolation of the hospitalized patient, and control measures, and provides images. Information about 2019-nCoV was added in February 2020. (Text)
02/05/2020 12:00 AM EST
Source: U.S. House of Representatives, Committee on Foreign Affairs. Published: 2/5/2020. This one-hour, 54-minute Congressional hearing features witnesses who discuss attempts to analyze and understand the risk the 2019 coronavirus (2019-nCoV) poses to the United States and other countries around the world, and recommendations for responding to the epidemic. They also discuss U.S.-China collaboration on pandemic response, especially in light of the coronavirus outbreak; the 2002–2003 outbreak of severe acute respiratory syndrome (SARS) and the global response; and lessons from the West African Ebola response to help save lives and protect the nation during the 2019-nCoV epidemic. (Video or Multimedia)
02/04/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/4/2020. This web page provides guidance for laboratories' requests for 2019-nCoV diagnostic tools, including how to order a reagent diagnostic tool, what the diagnostic tool includes, what other equipment labs will need to perform tests using the diagnostic tool, and what safety equipment labs should use when using the diagnostic tool. (Text)
02/04/2020 12:00 AM EST
Source: U.S. Food and Drug Administration (FDA). Published: 2/4/2020. This three-page document informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Centers for Disease Control and Prevention (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel. This test is to be performed only using respiratory specimens collected from individuals who meet CDC criteria for 2019-nCoV testing. (PDF)
02/04/2020 12:00 AM EST
Source: U.S. Food and Drug Administration (FDA). Published: 2/4/2020. The potential for transmission of novel coronavirus (2019-nCoV) by blood and blood components is unknown at this time. This web page provides information for blood establishments from the Food and Drug Administration (FDA), which is aware that some blood establishments are considering donor education and/or donor deferral measures in response to 2019-nCoV. As a precaution, blood establishments may wish to consider whether to provide donor education, encourage self-deferral, and manage post-donation information about 2019-nCoV. (Text)
02/03/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/3/2020. This 28-page strategic preparedness and response plan outlines the public health measures that the international community stands ready to provide to support all countries to prepare for and respond to 2019‑nCoV. The document takes what has been learned so far about the virus, and translates that knowledge into strategic action that can guide the efforts of all national and international partners when developing context‑specific national and regional operational plans. (PDF)
02/03/2020 12:00 AM EST
Source: Harvard University, Harvard T.H. Chan School of Public Health. Published: 2/3/2020. This 30-minute video from a Facebook Live Q&A provides an overview of the coronavirus (2019-n-CoV) outbreak, and discusses why it is more widespread than thought. Question topics include concerns for university populations, the effectiveness of travel bans, and routes of transmission. (Video or Multimedia)
02/01/2020 12:00 AM EST
Source: United Nations Office for Disaster Risk Reduction (UNDRR). Published: 2/2020. This 35-page guideline, updated in February 2020, aims at promoting smooth operations between existing guidance and initiatives to provide direction for risk-informed disaster preparedness for response, which is required to achieve the goals of the Sendai Framework. It targets actors working to strengthen risk-informed disaster preparedness within and across sectors and at all administrative levels in a country; highlights the key principles and required actions outlined in the Sendai Framework to enhance disaster preparedness for effective response in action; and points to existing resources that provide more detailed explanations and guidance by theme or stakeholder. (PDF)
02/01/2020 12:00 AM EST
Source: International Federation of Red Cross and Red Crescent Societies (IFRC). Published: 2/2020. This 14-page briefing note provides background knowledge on the mental health and psychosocial support (MHPSS) aspects related to 2019-nCoV and suggests MHPSS activities that can be implemented. The messages can be helpful for those in contact with patients or relatives and feel the strain of working and living during the epidemic. The briefing is aimed both at those working in any capacity with those affected by 2019-nCoV and for the MHPSS responders who implement MHPSS activities and interventions for everyone affected. (PDF)
02/01/2020 12:00 AM EST
Source: United Nations Office for Disaster Risk Reduction (UNDRR). Published: 2/2020. This 23-page guideline on design and conduct of simulation exercises (SIMEX) is a companion for implementing Sendai Framework Priority 4 on enhancing disaster preparedness for effective response. It consists of three main sections: General Information on Simulation Exercise, or SIMEX; the Process; and Existing Guidance. (PDF)
12/18/2019 12:00 AM EST
Source: National Network of Libraries of Medicine Pacific Southwest Region (NNLM PSR). Published: 12/18/2019. This 55-minute webinar discusses how libraries, librarians, and library patrons are impacted by disruptions to grid energy. Understanding the health impacts of utility shutoffs and the programs in place to protect medically vulnerable individuals is critical to anyone who lives or works in the path of natural disasters, and anyone who provides health information to medically vulnerable populations inside and outside of disaster zones. (Video or Multimedia)
11/05/2019 12:00 AM EST
Source: Center for Infectious Disease Research and Policy [University of Minnesota] (CIDRAP). Published: 11/5/2019. This one-hour, 12-minute video provides information for physicians, pharmacists, and other healthcare professionals about antibiotic selection using evidence-based clinical and laboratory considerations. Speakers discuss the benefits of de-escalation, including route and duration, as well as selecting and interpreting diagnostic tests that include traditional and rapid diagnostic assays. A comparison of diagnostic stewardship and antimicrobial stewardship is reviewed regarding how it leads to improved patient outcomes. (Video or Multimedia)
09/01/2019 12:00 AM EDT
Source: Federal Emergency Management Agency [Department of Homeland Security] (FEMA). Published: 9/2019. This 26-minute presentation discusses the fundamentals of electricity, vulnerabilities and power outages, and consequences of power outages. Emergency management considerations mentioned include establishing relationships with utility companies, conducting community outreach to educate the community on the impact of an extended power outage, and determining how an emergency management team is preparing for an extended power outage. (Video or Multimedia)
05/01/2019 12:00 AM EDT
Source: National Governors Association (NGA). Published: 5/2019. To help governors address the opioid epidemic, the National Governors Association Solutions: Center for Best Practices Health team (NGA Health) partnered with the Centers for Disease Control and Prevention and ChangeLab Solutions to share best and promising practices from Kentucky, the first southern state to authorize comprehensive harm reduction programs offering syringe exchange. This web page provides links to two publications that present insights from this work that can inform other governors’ efforts to prevent infectious disease outbreaks among people who inject opioids and other illicit drugs. (PDF)
No hay comentarios:
Publicar un comentario